NGMDF (NuGen Medical Devices) Cash-to-Debt: 0.10 (As of Mar. 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is NuGen Medical Devices Cash-to-Debt?

NuGen Medical Devices NGMDF Cash-to-Debt is 0.10 as of Mar. 2026, which is at its 10-year median of 0.10. The stock has 7 warning signs investors should review. Among 849 Medical Devices & Instruments companies, NuGen Medical Devices ranks worse than 91.4% on this metric.

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. NuGen Medical Devices's cash to debt ratio for the quarter that ended in Mar. 2026 was 0.10.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, NuGen Medical Devices couldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2026.

The historical rank and industry rank for NuGen Medical Devices's Cash-to-Debt or its related term are showing as below:

NGMDF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.02   Med: 0.1   Max: 0.49
Current: 0.1

During the past 6 years, NuGen Medical Devices's highest Cash to Debt Ratio was 0.49. The lowest was 0.02. And the median was 0.10.

NGMDF's Cash-to-Debt is ranked worse than
91.4% of 849 companies
in the Medical Devices & Instruments industry
Industry Median: 1.69 vs NGMDF: 0.10

NuGen Medical Devices  (OTCPK:NGMDF) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


NuGen Medical Devices Cash-to-Debt Related Terms


NuGen Medical Devices Cash-to-Debt Historical Data

* Premium members only.

The historical data trend for NuGen Medical Devices's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

NuGen Medical Devices Cash-to-Debt Chart

NuGen Medical Devices Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash-to-Debt
Get a 7-Day Free Trial 0.31 0.02 0.06 0.39 0.18

NuGen Medical Devices Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.31 0.23 0.18 0.10

NGMDF vs ABT, SYK, MDT: Cash-to-Debt Comparison

For the Medical Devices subindustry, NuGen Medical Devices's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NuGen Medical Devices Cash-to-Debt vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NuGen Medical Devices's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where NuGen Medical Devices's Cash-to-Debt falls into.



NuGen Medical Devices Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

NuGen Medical Devices's Cash to Debt Ratio for the fiscal year that ended in Dec. 2025 is calculated as:

NuGen Medical Devices's Cash to Debt Ratio for the quarter that ended in Mar. 2026 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash-to-Debt →
What does a Cash-to-Debt of 0.10 mean?
NuGen Medical Devices (NGMDF) has a Cash-to-Debt of 0.10 as of Mar. 2026. This is near median its historical median of 0.10. Over the past decade, NuGen Medical Devices' Cash-to-Debt has ranged from 0.02 to 0.49. According to the industry distribution chart, NuGen Medical Devices ranks #776 out of 849 companies in the Medical Devices & Instruments industry, placing it in the top 91.4%.
Is NuGen Medical Devices' Cash-to-Debt too high?
NuGen Medical Devices' current Cash-to-Debt of 0.10 is near median its 10-year median of 0.10. Over the past 10 years, this metric has ranged from a low of 0.02 to a high of 0.49. The Medical Devices & Instruments industry median Cash-to-Debt is 1.69. NuGen Medical Devices' value of 0.10 is 94.1% below this industry median. Based on the distribution chart, NuGen Medical Devices ranks #776 out of 849 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does NuGen Medical Devices' Cash-to-Debt compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, NuGen Medical Devices ranks #776 out of 849 companies for Cash-to-Debt. This places NuGen Medical Devices in the lower half of its industry. The industry median Cash-to-Debt is 1.69. NuGen Medical Devices' value of 0.10 is 94.1% below this benchmark. Historically, NuGen Medical Devices' own Cash-to-Debt has ranged from 0.02 to 0.49 over the past decade. While the company's 10-year median is 0.10 vs. the industry median of 1.69, NuGen Medical Devices has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Medical Devices & Instruments company?
The median Cash-to-Debt among Medical Devices & Instruments companies is 1.69, based on 849 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NuGen Medical Devices's current Cash-to-Debt of 0.10 is 94.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Cash-to-Debt is 1.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NuGen Medical Devices's current Cash-to-Debt is 0.10, which is near median its own 10-year median of 0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NuGen Medical Devices stock overvalued right now?
Based on GuruFocus' analysis, NuGen Medical Devices (NGMDF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.02, compared to a current price of $0.01 — trading 52.5% below its estimated fair value. The current Cash-to-Debt is 0.10, which is near median its 10-year median of 0.10 and 94.1% below the Medical Devices & Instruments industry median of 1.69. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For NuGen Medical Devices (NGMDF), the current Cash-to-Debt is 0.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NuGen Medical Devices Business Description

Other Exchanges 79O:GermanyNGMD:Canada
Address 18 King Street East, Suite 1400, Toronto, ON, CAN, M5C 1C4
NuGen Medical Devices Inc is a medical device manufacturing company specializing in the field of needleless injections and related technologies. The reportable segment of the company is the manufacturing of needle injector devices. Geographically, the company generates revenue from Europe, followed by Asia, and other.